Milestone Pharmaceuticals Inc. (MIST)

Milestone Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	42.5	25.31	13.76	7.64	114.14	72.31
Short-Term Investments	0.92	44.38	52.24	56.95	-	70
Cash & Short-Term Investments	43.42	69.7	66	64.59	114.14	142.31
Cash Growth	-47.85%	5.59%	2.20%	-43.42%	-19.79%	18.77%
Other Receivables	2	1.72	1.45	1.21	0.48	0.95
Receivables	2	1.72	1.45	1.21	0.48	0.95
Prepaid Expenses	0.75	1.84	3.18	6.01	4.3	5.43
Other Current Assets	-	0.67	2.4	-	-	-
Total Current Assets	46.17	73.93	73.03	71.8	118.92	148.69
Property, Plant & Equipment	1.25	1.57	2.19	2.68	0.93	1.29
Total Assets	47.42	75.5	75.23	74.48	119.85	149.97
Accounts Payable	8.77	1.93	3.98	2.26	4.38	4.64
Accrued Expenses	-	5.62	2.7	3.38	2.17	1.27
Current Portion of Leases	0.52	0.57	0.55	0.5	0.22	0.25
Total Current Liabilities	9.28	8.13	7.23	6.14	6.78	6.16
Long-Term Debt	55.24	53.35	49.77	-	-	-
Long-Term Leases	0.64	0.87	1.46	2	0.47	0.7
Total Liabilities	65.16	62.35	58.46	8.14	7.25	6.86
Common Stock	288.26	288.05	260.5	273.9	251.9	251.68
Additional Paid-In Capital	42.19	39.57	33.83	24.44	15.71	8.53
Retained Earnings	-401.27	-367.55	-326.03	-266.34	-207.95	-163.47
Comprehensive Income & Other	53.08	53.08	48.46	34.35	52.94	46.37
Total Common Equity	-17.75	13.15	16.77	66.35	112.6	143.12
Shareholders' Equity	-17.75	13.15	16.77	66.35	112.6	143.12
Total Liabilities & Equity	47.42	75.5	75.23	74.48	119.85	149.97
Total Debt	56.39	54.8	51.78	2.49	0.7	0.94
Net Cash (Debt)	-12.98	14.9	14.23	62.09	113.44	141.37
Net Cash Growth	-	4.71%	-77.09%	-45.26%	-19.75%	18.50%
Net Cash Per Share	-0.20	0.24	0.33	1.46	2.71	4.82
Filing Date Shares Outstanding	66.38	66.26	43.06	42.8	42.23	41.25
Total Common Shares Outstanding	66.38	66.26	43.06	42.8	42.23	41.25
Working Capital	36.89	65.8	65.81	65.66	112.15	142.53
Book Value Per Share	-0.27	0.20	0.39	1.55	2.67	3.47
Tangible Book Value	-17.75	13.15	16.77	66.35	112.6	143.12
Tangible Book Value Per Share	-0.27	0.20	0.39	1.55	2.67	3.47
Machinery	-	0.4	0.38	0.28	0.43	0.43
Leasehold Improvements	-	0.09	0.09	0.1	0.03	0.03

Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q